(Q46597238)

English

Severe persistent pulmonary hypertension of the newborn in a setting where limited resources exclude the use of inhaled nitric oxide: successful treatment with sildenafil

scientific article published on 13 July 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16012855

Severe persistent pulmonary hypertension of the newborn in a setting where limited resources exclude the use of inhaled nitric oxide: successful treatment with sildenafil (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16012855

persistent fetal circulation syndrome

1 reference

based on heuristic

inferred from title

author name string

Amadu E Juliana

1

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16012855

Filomena C B Abbad

2

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16012855

publication date

13 July 2005

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16012855

European Journal of Pediatrics

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16012855

164

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16012855

10

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16012855

626-629

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16012855

https://scigraph.springernature.com/pub.10.1007/s00431-005-1724-x

0 references

Intravenous sildenafil lowers pulmonary vascular resistance in a model of neonatal pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1007%2FS00431-005-1724-X

21 January 2018

Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/16012855

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

American Academy of Pediatrics. Committee on Fetus and Newborn. Use of inhaled nitric oxide

1 reference

https://pubmed.ncbi.nlm.nih.gov/16012855

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Low-Dose Nitric Oxide Therapy for Persistent Pulmonary Hypertension of the Newborn

1 reference

https://pubmed.ncbi.nlm.nih.gov/16012855

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Selective pulmonary vasodilation induced by aerosolized zaprinast.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16012855

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhaled nitric oxide for the early treatment of persistent pulmonary hypertension of the term newborn: a randomized, double-masked, placebo-controlled, dose-response, multicenter study. The I-NO/PPHN Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/16012855

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemotherapeutic potential of phosphodiesterase inhibitors

1 reference

https://pubmed.ncbi.nlm.nih.gov/16012855

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tissue distribution of phosphodiesterase families and the effects of sildenafil on tissue cyclic nucleotides, platelet function, and the contractile responses of trabeculae carneae and aortic rings in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/16012855

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Persistent pulmonary hypertension of the newborn in the era before nitric oxide: practice variation and outcomes

1 reference

https://pubmed.ncbi.nlm.nih.gov/16012855

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. The Inhaled Nitric Oxide Study Group.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16012855

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nebulized sildenafil is a selective pulmonary vasodilator in lambs with acute pulmonary hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/16012855

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nitric oxide for respiratory failure in infants born at or near term

1 reference

https://pubmed.ncbi.nlm.nih.gov/16012855

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nitric oxide in the pathogenesis of sepsis

1 reference

https://pubmed.ncbi.nlm.nih.gov/16012855

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phosphodiesterase inhibitors for persistent pulmonary hypertension of the newborn: A review

1 reference

https://pubmed.ncbi.nlm.nih.gov/16012855

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized, multicenter trial of inhaled nitric oxide and high-frequency oscillatory ventilation in severe, persistent pulmonary hypertension of the newborn

1 reference

https://pubmed.ncbi.nlm.nih.gov/16012855

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nitric oxide and cGMP cause vasorelaxation by activation of a charybdotoxin-sensitive K channel by cGMP-dependent protein kinase

1 reference

https://pubmed.ncbi.nlm.nih.gov/16012855

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Images in congenital heart disease. Reversal of shunting in pulmonary hypertension after treatment with oral Sildenafil

1 reference

https://pubmed.ncbi.nlm.nih.gov/16012855

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sildenafil is a pulmonary vasodilator in awake lambs with acute pulmonary hypertension.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16012855

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Low-dose nitric oxide therapy for persistent pulmonary hypertension: 1-year follow-up

1 reference

https://pubmed.ncbi.nlm.nih.gov/16012855

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00431-005-1724-X

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16012855

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16012855

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46597238&oldid=2121320533"